AUTONOMIX MEDICAL, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
AUTONOMIX MEDICAL, INC. (AMIX) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $0 for the 3-month period ending 2025-03-31, per its 10-K filed 2025-05-29.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2025-05-29
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-03-31 was $0.00.
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2024-12-31 was $0.00.
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2024-09-30 was $0.00.
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2024-06-30 was $0.00.
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2025 was $0.00.
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2024 was -$4.56M.
- AUTONOMIX MEDICAL, INC. gain (loss) on derivative instruments, net, pretax for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-05-29 | $0.00 derived: sum of 2 quarters · filed 2025-05-29 | $0.00 derived: sum of 3 quarters · filed 2025-05-29 | $0.00 10-K · filed 2025-05-29 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | -$4.56M derived: sum of 4 quarters · filed 2025-05-29 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | -$4.56M derived: sum of 3 quarters · filed 2025-05-29 | -$4.56M derived: sum of 4 quarters · filed 2025-05-29 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2025-05-29 | -$4.56M derived: sum of 2 quarters · filed 2025-05-29 | -$4.56M derived: sum of 3 quarters · filed 2025-05-29 | -$9.11M derived: sum of 4 quarters · filed 2025-05-29 |
| 2024-03-31 | -$4.56M 10-K · filed 2025-05-29 | -$4.56M derived: sum of 2 quarters · filed 2025-05-29 | -$9.11M derived: sum of 3 quarters · filed 2025-05-29 | -$4.56M 10-K · filed 2025-05-29 |
| 2023-12-31 | $0.00 10-Q · filed 2025-02-13 | -$4.56M derived: sum of 2 quarters · filed 2025-02-13 | -$4.56M 10-Q · filed 2025-02-13 | |
| 2023-09-30 | -$4.56M 10-Q · filed 2024-11-08 | -$4.56M 10-Q · filed 2024-11-08 | ||
| 2023-03-31 | $0.00 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |